Received May 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 5H95B | — |
received Kinrix at 7 years and 5 days old; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 6-year-old female patient who received DTPa-IPV (Kinrix) (batch number 5H95B) for prophylaxis. On 22-APR-2025, the patient received Kinrix. On 22-APR-2025, an unknown time after receiving Kinrix, the patient experienced inappropriate age at vaccine administration (Verbatim: received Kinrix at 7 years and 5 days old). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-APR-2025 Health care professional reported that a child received Kinrix at 7 years and 5 days old, which led to inappropriate age at vaccine administration.